Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer.
New Hope For Esophageal Cancer Patients — Immunotherapy Opdivo Approved For Treatment Of Advanced Esophageal Cancer
Checkpoint inhibitor OPDIVO has shown tremendous promise for patients battling advanced esophageal cancer.